Does RADIUM RA-223 DICHLORIDE Cause Unevaluable event? 13 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Unevaluable event have been filed in association with RADIUM RA-223 DICHLORIDE (Xofigo). This represents 0.3% of all adverse event reports for RADIUM RA-223 DICHLORIDE.
13
Reports of Unevaluable event with RADIUM RA-223 DICHLORIDE
0.3%
of all RADIUM RA-223 DICHLORIDE reports
2
Deaths
2
Hospitalizations
How Dangerous Is Unevaluable event From RADIUM RA-223 DICHLORIDE?
Of the 13 reports, 2 (15.4%) resulted in death, 2 (15.4%) required hospitalization.
Is Unevaluable event Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RADIUM RA-223 DICHLORIDE. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does RADIUM RA-223 DICHLORIDE Cause?
Prostatic specific antigen increased (449)
Hormone-refractory prostate cancer (441)
Death (376)
Anaemia (324)
Metastases to bone (315)
General physical health deterioration (308)
Fatigue (242)
Haemoglobin decreased (236)
Prostate cancer (234)
Nausea (221)
What Other Drugs Cause Unevaluable event?
ADALIMUMAB (4,242)
ETANERCEPT (3,902)
LENALIDOMIDE (3,331)
OXYCODONE (3,145)
AMBRISENTAN (2,336)
SODIUM OXYBATE (2,328)
CARBIDOPA\LEVODOPA (1,632)
DUPILUMAB (1,410)
MORPHINE (1,161)
ACETAMINOPHEN\HYDROCODONE (1,118)
Which RADIUM RA-223 DICHLORIDE Alternatives Have Lower Unevaluable event Risk?
RADIUM RA-223 DICHLORIDE vs RALOXIFENE
RADIUM RA-223 DICHLORIDE vs RALTEGRAVIR
RADIUM RA-223 DICHLORIDE vs RALTITREXED
RADIUM RA-223 DICHLORIDE vs RAMELTEON
RADIUM RA-223 DICHLORIDE vs RAMIPRIL